QOF NHS: Maximize your AFib earnings in 2023/24

  • Powerful Medical
  • April 13, 2023
  • 6 min to read
Smiling GP in white coat with stethoscope next to the PMcardio AI ECG app logo

Discover how PMcardio enhances GP practices’ QOF earnings from AFib management with accurate and timely ECG interpretation.

What is QOF in NHS

In the United Kingdom, the Quality and Outcomes Framework (QOF) is a program that has been designed to evaluate the performance of National Health Service (NHS) GP practices. The QOF provides a financial incentive for GP practices to deliver high-quality healthcare services and improve patient outcomes. To achieve this, the QOF allocates points to GP practices for meeting specific targets related to patient care.

Source: Quality and Outcomes Framework guidance for 2023/24

Improve your QOF score by stellar AFib detection

The QOF plays a significant role in the financial health of NHS GP practices, as it directly impacts their income. The more QOF points a practice earns, the higher its income will be. Therefore, earning QOF points is important not only for improving patient care but also for the financial sustainability of GP practices. This blog post will explore how GP practices can leverage PMcardio’s accurate and timely AI-powered ECG interpretation including AFib detection capabilities to increase their QOF earnings.

Smiling GP in white coat with stethoscope beside the PMcardio AI ECG app logo

QOF in NHS: Payment Calculation and Analysis System

Within the framework of the General Medical Services contract’s Quality and Outcomes Framework (QOF), the process of recording achievement is managed through the Payment Calculation and Analysis System (PCAS). Results find their way into this system by two means: an automatic extraction from patients’ electronic health records within GP clinical systems or manual input. Critical to this process, datasets and accompanying business rules provide a structured framework that outlines the logic and sequence governing the extraction of numerator and denominator data for the determination of indicator achievement.

Try PMcardio for Free​

Join 100,000+ healthcare professionals using the world’s most advanced ECG reader app. Experience faster, smarter cardiac care—starting with 5 FREE ECGs/month. No credit card required.

AFib in the Clinical Domain: Rationale for Its Inclusion in QOF

Atrial fibrillation (Afib or AF) stands as the most prevalent heart rhythm disorder, impacting about 2% of the adult population, with indications that its incidence is on the rise. Afib can manifest as palpitations and breathlessness in many individuals, but it can also remain asymptomatic, eluding detection. If left untreated, Afib poses a substantial risk for stroke, contributing to an estimated 20% of all strokes, along with increased mortality and significant morbidity. This condition tends to affect men more frequently than women and becomes more prevalent with age and in conjunction with heart disease, diabetes, obesity, and hypertension.

QOF 2023/24: Afib Indicator set

QOF AFib indicators AF001 AF006 AF008 with 2022/23 point values and potential GP practice earnings
Source: Quality and Outcomes Framework guidance for 2023/24

AFib QOF earnings in 2023/24

For the 2023/24 year, the average QOF point value is £213.43. With a practice size of 10,000 patients, this would make the maximum potential earnings from these earnings £6,189.47 per year. To calculate this for your appropriate practice size, the Contractor Population Index (CPI) is a tool that adjusts your QOF payments based on the relevant size of your practice’s patient list.

Improve your QOF earnings with PMcardio

PMcardio’s AI-powered ECG analysis is revolutionising the diagnosis of A-Fib, achieving an impressive 97% sensitivity and 99% specificity. With 5x better diagnostic precision when compared to the current state-of-the-art, GP practices can more effectively identify patients suffering from A-Fib, ensuring they receive the appropriate management and treatment in a timely manner.

PMcardio not only excels in diagnostics but also assists healthcare professionals by calculating the CHA2DS2-VASc score and providing recommendations for anticoagulation therapy. These recommendations adhere to established guidelines, ensuring that patients receive the most appropriate treatment.

QOF indicators seamless alignment with PM cardio

This comprehensive approach to patient care directly corresponds to QOF indicators, making PMcardio an invaluable tool for healthcare providers seeking to improve their practice’s performance and quality of care in managing A-Fib patients. Additionally, by using PMcardio to diagnose and manage A-Fib patients, GP practices have the potential to achieve maximum QOF points in relation to A-Fib, leading to increased earnings.

Utilizing PMcardio for the diagnosis and management of patients with atrial fibrillation, GP practices can unlock the potential to attain the highest possible QOF points for AFib, resulting in maximizing their earnings.

QOF 2023/24 AFib indicators AF001 AF006 AF008 describing register, CHA2DS2-VASc stroke risk and anticoagulation
Source: Quality and Outcomes Framework guidance for 2023/24

Elevate your practice with PMcardio

Utilizing advanced algorithms and data-driven insights, PMcardio’s AI system streamlines the diagnostic process. This improved diagnostic capability not only benefits individual patients but also contributes to overall public health by promoting early intervention and better management of this common yet potentially serious cardiovascular condition. The accurate and efficient identification of A-Fib cases can help reduce the burden on healthcare systems by enabling targeted interventions and reducing the risk of complications, such as stroke or heart failure. Give PM cardio a try and get your first 5 ECGs for free.

Share this article

  • Share on Facebook
  • Share on X
  • Share on Linkedin
  • Share via e-mail
  • Copy the link
About PMcardio logo

About PMcardio

PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.

About Product

About Powerful Medical  logo

About Powerful Medical

Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.

About Us